Snapshot from Jun 26, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Éimear Foley
Person

Éimear Foley

Tracked across 1 events · 9 articles · First seen May 20, 2026 · Last active May 29, 2026

Sentiment
20
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 20
Tech
Tocilizumab shows promise for depression
A University of Bristol-led clinical trial, published in JAMA Psychiatry, suggests that Tocilizumab>>>, an anti-inflammatory drug typically used for conditions like Rheumatoid arthritis, may offer a new treatment pathway for difficult-to-treat Depression (mood)>>>. The small…
Impact: Éimear Foley>>> is the lead author of the study, emphasizing the potential for more tailored Depression (mood)>>> care based on individual biology.
May 20, 2026 · 9 articles
NEWSDESK
Track Éimear Foley live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.